VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
MHUA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
MHUAMeihua International Medical Technologies Co., Ltd.
$7.61$2M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksMHUACash Flow

Meihua International Medical Technologies Co., Ltd. (MHUA) Cash Flow Statement

7Y historyFree accessUpdated daily

Free cash flow volatility is pronounced, with a negative 26.1% FCF margin in 2025Q2 driven by a $9.9M outflow in working capital.

Income StatementBalance SheetCash FlowRatios

MHUA Cash Flow Statement

Annual statement

MHUA Cash Flow Statement

Meihua International Medical Technologies Co., Ltd. (MHUA) cash flow statement — 7-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18
Cash from Operations2.53M14.64M2.28M-9.16M-54.66K5.33M9.31M11.82M
Operating CF Margin %-15.1%2.34%-8.87%-0.05%5.98%11.69%15.61%
Operating CF Growth %-1189.6%543.16%124.84%-16662.78%-101.03%-42.78%-21.23%-
Net Income18.55M10.84M11.59M6.18M19.99M19.05M15.43M15.48M
Depreciation & Amortization1.02M571.03K470.99K563.46K622.47K523.43K509.22K567.77K
Stock-Based Compensation00000000
Deferred Taxes0-642.63K-370.48K00000
Other Non-Cash Items-5.99M3.9M2.18M4.51M15.28K2.85K-9.53K6.71M
Working Capital Changes-11.05M-27.97K-11.6M-20.41M-20.68M-14.25M-6.62M-10.94M
Change in Receivables-13.91M-3.21M-14.02M-7.12M-20.07M-13.64M-4.71M-11.09M
Change in Inventory575.72K165.76K-528.63K35.03K105.12K-219.79K802.61K-170.6K
Change in Payables0932.49K185.9K-3.37M4.91M5.34M-4.23M0
Cash from Investing-16.84M-20.42M-12.46M-8.62M-833.82K-16.09M-8.9M-7.57M
Capital Expenditures-324.57K-133.55K-1.18M-2.7M-850.23K-16.12M-8.95M-12.3K
CapEx % of Revenue0.18%0.14%1.22%2.61%0.82%18.1%11.24%0.02%
Acquisitions0-89.72K0658.46K16.41K25.2K50.6K0
Investments--------
Other Investing-16.51M-15.9M-11.63M23.15K000-7.56M
Cash from Financing12.82M6.21M706.13K37.25M1.86M1.71M923.77K-4.2M
Debt Issued (Net)6.62M6.41M706.13K2.08M1.86M434.52K579.03K0
Equity Issued (Net)-200K-200K01000K01000K00
Dividends Paid00000000
Share Repurchases-200K-200K000000
Other Financing6.4M00635.31K00344.74K-4.2M
Net Change in Cash-71.78K362.07K-9.81M18.59M961.94K-8.84M1.23M-794.34K
Free Cash Flow12.11M14.5M-2.41M-11.86M-904.89K-10.79M356.12K11.8M
FCF Margin %6.59%14.97%-2.48%-11.48%-0.87%-12.12%0.45%15.59%
FCF Growth %157.8%701.59%79.68%-1210.85%91.62%-3130.93%-96.98%-
FCF per Share37.9652.99-10.07-50.67-3.83-44.711.4859.02
FCF Conversion (FCF/Net Income)0.65x1.35x0.20x-1.47x-0.00x0.28x0.60x0.76x
Interest Paid129.86K247.62K250.78K194.67K180.74K137.16K97.79K0
Taxes Paid03.66M3.58M5.7M5.04M4.36M3.9M0

Key Metrics

Growth RegimeContracting
ProfitabilityStrained
Balance SheetHealthy
Cash FlowDeteriorating
Top Statement Risk

Working Capital Liquidity Risk

Earnings Quality Decoupled From Cash

According to recent financial disclosures, MHUA's operating cash flow to net income ratio reached a concerning -6.30 in 2025Q2, highlighting a severe disconnect between reported accounting profits and the actual cash generated from core operations during the most recent quarterly reporting period.

The persistent inability to convert net income into operating cash flow suggests that the company's earnings quality is significantly compromised by non-cash accruals or delayed collections. Investors should monitor whether this divergence reflects structural issues in revenue recognition or simply an aggressive buildup of receivables that may never materialize as cash.

Free Cash Flow Volatility Persists

As reported in the company's cash flow statements, MHUA's free cash flow margin plummeted to -26.1% in 2025Q2, marking a sharp reversal from the positive 26.2% margin achieved in 2024Q4 and underscoring the extreme instability inherent in the firm's current cash generation profile.

The erratic nature of free cash flow suggests that the business model is highly sensitive to working capital swings rather than consistent operational performance. This volatility makes it difficult to rely on internal cash generation to fund future growth or maintain the current dividend policy, if any.

Working Capital Dragging Cash Flow

Based on the provided quarterly data, MHUA experienced a massive working capital outflow of $9.9M in 2025Q2, which directly mirrors the negative operating cash flow and indicates that the company is struggling to manage its cash conversion cycle effectively in the current environment.

The recurring negative working capital changes suggest that the company is effectively financing its customers' operations through extended payment terms. This trend warrants further investigation into the credit quality of the hospital systems MHUA serves and the potential for future write-downs of aged accounts receivable.

Cumulative Earnings Mask Cash Reality

Data from the last ten quarters reveals a consistent pattern where net income frequently exceeds operating cash flow, with the cumulative gap suggesting that reported profitability may be significantly overstated relative to the actual cash liquidity available to the firm's balance sheet over time.

This long-term divergence implies that the company's growth has been largely funded by accounting accruals rather than organic cash generation. Analysts should be wary of this trend, as it often precedes a period of liquidity stress when the underlying receivables eventually fail to convert into cash.

MHUA — Frequently Asked Questions

Quick answers to the most common questions about buying MHUA stock.

How much cash does Meihua International Medical Technologies Co., Ltd. (MHUA) generate from operations?

Meihua International Medical Technologies Co., Ltd. (MHUA) generated $14.6M in net cash from operating activities in 2024. This reflects the cash generated directly from core business operations.

What is Meihua International Medical Technologies Co., Ltd.'s free cash flow?

Meihua International Medical Technologies Co., Ltd. (MHUA) generated $14.5M in free cash flow in 2024. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Meihua International Medical Technologies Co., Ltd.'s capital expenditure (CapEx)?

Meihua International Medical Technologies Co., Ltd. (MHUA) spent $0.1M on capital expenditures in 2024. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Meihua International Medical Technologies Co., Ltd. distribute cash to shareholders?

In 2024, Meihua International Medical Technologies Co., Ltd. (MHUA) spent $0.2M on share repurchases. This shows the company's commitment to returning capital to its equity investors.